Show
Sort by
-
Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis
-
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
-
Modeling the probability for rheumatoid arthritis during diagnostic work-up: How to combine the results of ACPA, RF and HLA-SE testing?
-
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition
-
Comparison of the anti-human citrullinated fibrinogen antibodies assayed by ELISA with 2 other ACPA assays: Diagnostic value and agreement between assays
-
Anti-TNFalpha induced apoptosis contributes to the induction of autoantibodies but not the decrease of synovial inflammation in spondyloarthropathy
-
Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis
-
Which patients with ankylosing spondylitis start anti-TNF-alpha therapy in daily clinical practice?
-
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progession in patients with ankylosing spondylitis (AS)
-
Belgian patients with familial and sporadic ankylosing spondylitis differ in disease phenotype
-
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
-
Polymorphisms in the ficolin 1 gene (Fcn1) are associated with susceptibility to the development of rheumatoid arthritis
-
Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus - An international meta-analysis
-
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis
-
Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity : biologic and clinical implications in autoimmune arthritis
-
S100A12-expression is upregulated by TNF and may serve as a marker for the success of anti-TNF therapy
-
Growth promoting effect of human cartilage glycoprotein-39 (HC gp-39)on synovial fibroblasts
-
Local production of the cartilage protein melanoma inhibitory activity (MIA) in the inflamed joint: Disease specificity, regulation by IL-1, and association with radiological joint damage
-
Tumor necrosis factor a blockade treatment down-modulates the increased systemic and local expression of toll-like receptor 2 and toll-like receptor 4 in spondylarthropathy
-
Potent anti-inflammatory, fully dissociative compound for glucocorticoid receptor-mediated gene regulation